PUPO, LIVIO
 Distribuzione geografica
Continente #
NA - Nord America 1.517
EU - Europa 155
AS - Asia 104
SA - Sud America 2
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 1.780
Nazione #
US - Stati Uniti d'America 1.516
SG - Singapore 73
IT - Italia 54
CN - Cina 26
IE - Irlanda 26
RU - Federazione Russa 17
FR - Francia 10
UA - Ucraina 9
DE - Germania 8
SE - Svezia 7
GB - Regno Unito 5
BE - Belgio 4
FI - Finlandia 4
KR - Corea 4
CZ - Repubblica Ceca 3
NL - Olanda 3
BR - Brasile 2
PL - Polonia 2
AE - Emirati Arabi Uniti 1
AT - Austria 1
CA - Canada 1
CH - Svizzera 1
EE - Estonia 1
EU - Europa 1
NZ - Nuova Zelanda 1
Totale 1.780
Città #
Wilmington 451
Houston 416
Woodbridge 147
Chandler 92
Singapore 67
Fairfield 60
New York 36
Rome 34
Ashburn 33
Seattle 33
Cambridge 31
Dublin 26
Ann Arbor 23
Medford 20
Santa Clara 16
Beijing 13
Lawrence 10
Dearborn 9
San Diego 8
Menlo Park 6
Moscow 5
Brussels 4
Palo Alto 4
Redwood City 4
Seoul 4
Brno 3
Center 3
Engelhard 3
Helsinki 3
Mountain View 3
Picinisco 3
Shanghai 3
Ancenis 2
Chengdu 2
Creede 2
Jacksonville 2
Kilburn 2
Mozzecane 2
Munich 2
São Paulo 2
Zhengzhou 2
Amandola 1
Amsterdam 1
Augusta 1
Bari 1
Changsha 1
Chaoyang 1
Chicago 1
Dubai 1
Frankfurt am Main 1
Halifax 1
Hefei 1
Islington 1
Jinan 1
Kraków 1
London 1
Milan 1
Nanchang 1
Norwalk 1
Nuremberg 1
Pescara 1
Rimini 1
Saint Petersburg 1
Sarno 1
Tallinn 1
Turin 1
Verona 1
Vienna 1
Totale 1.618
Nome #
Venetoclax: Bcl-2 inhibition for the treatment of chronic lymphocytic leukemia 343
Molecular expression of bone marrow angiogenic factors, cell-cell adhesion molecules and matrix-metallo-proteinases in plasmacellular disorders: A molecular panel to nvestigate disease progression 243
Remission of an HHV8-related extracavitary primary effusion lymphoma in an HIV-positive patient during antiretroviral treatment containing dolutegravir 181
Recurrent Sweet's syndrome in a patient with multiple myeloma 160
The Efficacy and Safety of Lenalidomide plus Rituximab in an Orbital Relapse of Diffuse Large B-Cell Lymphoma 151
Primary Cutaneous Anaplastic Large Cell Lymphoma of the Oral Cavity Successfully Treated with Brentuximab Vedotin 150
The neutrophil/lymphocyte ratio ≥3.5 is a prognostic marker in diffuse large B-cell lymphoma: a retrospective analysis from the database of the Italian regional network ‘Rete Ematologica del Lazio per i Linfomi’ (RELLI) 149
BEAM vs FEAM high-dose chemotherapy: retrospective study in lymphoma patients undergoing autologous stem cell transplant 142
Comparison between biosimilar filgrastim vs other granulocyte-colony stimulating factor formulations (originator filgrastim, peg-filgrastim and lenograstim) after autologous stem cell transplantation: a retrospective survey from the Rome Transplant Network 117
A case of metachronous peripheral T-Cell non-Hodgkin lymphoma following chemotherapy for Hodgkin disease successfully treated with brentuximab vedotin 100
Prophylaxis with Tixagevimab/Cilgavimab in chronic lymphocytic leukaemia, a case control study 57
Recurrent Sweet's syndrome in a patient with multiple myeloma 36
Totale 1.829
Categoria #
all - tutte 5.529
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.529


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020400 0 0 0 0 29 34 32 23 55 106 67 54
2020/2021577 62 63 89 61 54 75 69 58 8 25 9 4
2021/202294 3 10 1 3 1 7 11 5 12 3 11 27
2022/2023200 13 21 3 23 25 33 36 12 23 1 6 4
2023/202492 8 2 13 1 6 36 7 1 3 0 0 15
2024/2025161 32 82 27 14 6 0 0 0 0 0 0 0
Totale 1.829